Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker PGEN
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Jeffrey B. Kindler Director | PGEN Precigen, Inc. | Sale | 185,000 | $7.44 | $1.4M Sale | Form 4 ↗ |
| Aug 25, 2026 | Rutul R. Shah Chief Operating Officer | PGEN Precigen, Inc. | Sale | 15,342 | $7.50 | $115.1K Sale | Form 4 ↗ |
| Aug 25, 2026 | Phil Tennant Chief Commercial Officer | PGEN Precigen, Inc. | Sale | 79,166 | $7.50 | $593.7K Sale | Form 4 ↗ |
| Aug 21, 2026 | Nancy H. Agee Director | PGEN Precigen, Inc. | Buy | 3,411 | $7.23 | $24.7K Buy | Form 4 ↗ |
| Aug 21, 2026 | Rutul R. Shah Chief Operating Officer | PGEN Precigen, Inc. | Sale | 34,658 | $7.50 | $259.9K Sale | Form 4 ↗ |
| Aug 6, 2026 | Rutul R. Shah Chief Operating Officer | PGEN Precigen, Inc. | Sale | 32,739 | $6.86 | $224.6K Sale | Form 4 ↗ |
| Aug 3, 2026 | Rutul R. Shah Chief Operating Officer | PGEN Precigen, Inc. | Sale | 33,772 | $6.50 | $219.5K Sale | Form 4 ↗ |
| Jul 31, 2026 | Harry Thomasian Jr. Chief Financial Officer | PGEN Precigen, Inc. | Sale | 100,000 | $6.06 | $606.0K Sale | Form 4 ↗ |
| Jul 1, 2026 | Harry Thomasian Jr. Chief Financial Officer | PGEN Precigen, Inc. | Sale | 171,429 | $5.53 | $948.0K Sale | Form 4 ↗ |
| Jun 29, 2026 | Harry Thomasian Jr. Chief Financial Officer | PGEN Precigen, Inc. | Sale | 28,571 | $5.78 | $165.1K Sale | Form 4 ↗ |
| Jun 29, 2026 | Rutul R. Shah Chief Operating Officer | PGEN Precigen, Inc. | Sale | 42,924 | $5.85 | $251.1K Sale | Form 4 ↗ |
| Jun 29, 2026 | Helen Sabzevari President and CEO | PGEN Precigen, Inc. | Sale | 346,836 | $5.89 | $2.0M Sale | Form 4 ↗ |
| May 28, 2026 | Harry Thomasian Jr. Chief Financial Officer | PGEN Precigen, Inc. | Sale | 41,884 | $4.36 | $182.6K Sale | Form 4 ↗ |
| May 28, 2026 | Phil Tennant Chief Commercial Officer | PGEN Precigen, Inc. | Sale | 30,272 | $4.36 | $132.0K Sale | Form 4 ↗ |
| May 28, 2026 | Rutul R. Shah Chief Operating Officer | PGEN Precigen, Inc. | Sale | 42,703 | $4.36 | $186.2K Sale | Form 4 ↗ |
| May 28, 2026 | Donald P. Lehr Chief Legal Officer | PGEN Precigen, Inc. | Sale | 29,131 | $4.36 | $127.0K Sale | Form 4 ↗ |
| May 28, 2026 | Helen Sabzevari President and CEO | PGEN Precigen, Inc. | Sale | 119,250 | $4.36 | $519.9K Sale | Form 4 ↗ |
| Mar 30, 2026 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 2.33M | $3.30 | $7.7M Sale | Form 4 ↗ |
| Mar 30, 2026 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 23,789 | $3.30 | $78.5K Sale | Form 4 ↗ |
| Mar 30, 2026 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 38,976 | $3.30 | $128.6K Sale | Form 4 ↗ |
| Mar 30, 2026 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 47,101 | $3.30 | $155.4K Sale | Form 4 ↗ |
| Mar 30, 2026 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 168,794 | $3.30 | $557.0K Sale | Form 4 ↗ |
| Mar 30, 2026 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 426,199 | $3.30 | $1.4M Sale | Form 4 ↗ |
| Mar 30, 2026 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 50,797 | $3.30 | $167.6K Sale | Form 4 ↗ |
| Mar 30, 2026 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 152,063 | $3.30 | $501.8K Sale | Form 4 ↗ |
| Mar 30, 2026 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 370,847 | $3.30 | $1.2M Sale | Form 4 ↗ |
| Mar 30, 2026 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 50,797 | $3.30 | $167.6K Sale | Form 4 ↗ |
| Mar 30, 2026 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 1.11M | $3.30 | $3.7M Sale | Form 4 ↗ |
| Dec 22, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 956,200 | $4.18 | $4.0M Sale | Form 4 ↗ |
| Dec 22, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 5,958 | $4.18 | $24.9K Sale | Form 4 ↗ |
| Dec 22, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 9,931 | $4.18 | $41.5K Sale | Form 4 ↗ |
| Dec 22, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 11,917 | $4.18 | $49.8K Sale | Form 4 ↗ |
| Dec 22, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 42,702 | $4.18 | $178.5K Sale | Form 4 ↗ |
| Dec 22, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 159,321 | $4.18 | $666.0K Sale | Form 4 ↗ |
| Dec 22, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 12,909 | $4.18 | $54.0K Sale | Form 4 ↗ |
| Dec 22, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 38,729 | $4.18 | $161.9K Sale | Form 4 ↗ |
| Dec 22, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 94,341 | $4.18 | $394.3K Sale | Form 4 ↗ |
| Dec 22, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 12,909 | $4.18 | $54.0K Sale | Form 4 ↗ |
| Dec 22, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 555,119 | $4.18 | $2.3M Sale | Form 4 ↗ |
| Dec 12, 2025 | Jeffrey B. Kindler Director | PGEN Precigen, Inc. | Sale | 235,467 | $3.63 | $854.7K Sale | Form 4 ↗ |
| Nov 21, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 937,308 | $3.83 | $3.6M Sale | Form 4 ↗ |
| Nov 20, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 942,832 | $4.08 | $3.8M Sale | Form 4 ↗ |
| Nov 19, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 1.09M | $4.47 | $4.9M Sale | Form 4 ↗ |
| Sep 30, 2025 | Randal J. Kirk Director, 10% owner | PGEN Precigen, Inc. | Sale | 1.81M | $3.41 | $6.2M Sale | Form 4 ↗ |
| Sep 30, 2025 | Jeffrey B. Kindler Director | PGEN Precigen, Inc. | Sale | 106,837 | $3.38 | $361.1K Sale | Form 4 ↗ |
| Sep 29, 2025 | Jeffrey B. Kindler Director | PGEN Precigen, Inc. | Sale | 67,523 | $3.60 | $243.1K Sale | Form 4 ↗ |
| Sep 29, 2025 | Phil Tennant Chief Commercial Officer | PGEN Precigen, Inc. | Buy | 6,000 | $3.58 | $21.5K Buy | Form 4 ↗ |
| Sep 26, 2025 | Rutul R. Shah Chief Operating Officer | PGEN Precigen, Inc. | Buy | 2,000 | $3.40 | $6,800 Buy | Form 4 ↗ |
| Sep 26, 2025 | Harry Thomasian Jr. Chief Financial Officer | PGEN Precigen, Inc. | Buy | 2,932 | $3.42 | $10.0K Buy | Form 4 ↗ |
| Sep 25, 2025 | Harry Thomasian Jr. Chief Financial Officer | PGEN Precigen, Inc. | Buy | 8,284 | $3.62 | $30.0K Buy | Form 4 ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:55 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances